US Stocks
/
Cardiff Oncology, Inc. Share Price

Cardiff Oncology, Inc. Share Price

NASDAQ: CRDF | Micro Cap
$1.08
+$0.02 (1.89%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cardiff Oncology, Inc. Stock Performance

Open
$1.08
Prev. Close
$1.06
Circuit Range
N/A
Day Range
$1.08 - $1.10
Year Range
$0.76 - $3.31
Volume
20,438
Average Traded
$1.09

Cardiff Oncology, Inc. Share Price Today

As of 11 October 2026, Cardiff Oncology, Inc.'s share price is $1.08. The stock opened at $1.08, compared to its previous close of $1.06. During today's trading session, Cardiff Oncology, Inc.'s share price traded between $1.08 and $1.10, with an average price of $1.09. Over the past 52 weeks, the stock has recorded a high of $3.31 and a low of $0.76. In terms of performance, Cardiff Oncology, Inc.'s share price has declined by 37.39% over the last six months and is down 54.14% on a year-on-year basis.

Cardiff Oncology, Inc. Share Price Chart

$1.08$1.10
L
Show Current Price
H

Cardiff Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$72.19M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.52
Revenue (TTM)
$590.00M
Return On Equity (TTM)
-151.05%
Profit Margin
-7776.27%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
17.94%

Cardiff Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.12$0.24$0.04$0.10
Net Profit-$11.26-$7.22-$12.35-$9.24
Net Profit Margin-9383.33%-3008.33%-30875.00%-9240.00%
Income ChangeN/A35.88%-71.05%25.18%

Cardiff Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.39$0.49$0.68$0.59
Net Profit-$38.73-$41.47-$45.46-$45.88
Net Profit Margin-9930.77%-8463.27%-6685.29%-7776.27%
Income ChangeN/A-7.07%-9.62%-0.92%

About Cardiff Oncology, Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.

Cardiff Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.20
$1.09
-9.17%
Sep 2026
$1.02
$1.20
+21.46%
Aug 2026
$0.87
$0.99
+14.88%
Jul 2026
$1.29
$0.86
-33.59%
Jun 2026
$1.68
$1.29
-32.20%
May 2026
$1.74
$1.91
+10.72%
Apr 2026
$1.69
$1.73
+6.15%
Mar 2026
$1.87
$1.63
-15.80%
Feb 2026
$1.70
$1.93
+10.92%
Jan 2026
$2.79
$1.74
-37.97%
Dec 2025
$2.25
$2.81
+23.03%
Nov 2025
$2.34
$2.28
-3.18%

CRDF Share Price FAQs

What is Cardiff Oncology, Inc. share price today?

chevron-up
Cardiff Oncology, Inc. share price today is $1.08 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cardiff Oncology, Inc. stock?

chevron-up
The 52 week high of Cardiff Oncology, Inc. stock is $3.31, while the 52 week low is $0.76 as of 10 Oct '26.

What is CRDF's market capitalisation today?

chevron-up
CRDF market capitalisation is $72.19M as of October 11, 2026, at 4:04 pm IST.

What is CRDF's net income for the last quarter?

chevron-up
CRDF's net income for the last quarter is -9.24B USD.

What is the 5 year returns of CRDF?

chevron-up
The 5 year returns of CRDF is -81.57% as on 10 Oct '26.

What is the high & low stock price of CRDF today?

chevron-up
CRDF stock price hit a high of $1.10 and low of $1.08 as of 10 Oct '26.

Can I buy CRDF shares in India?

chevron-up
Yes. You can buy CRDF in India by opening an international trading account.